Tango Therapeutics CEO Barbara Weber's 2022 pay falls 59% to $4.7M
Tango Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 24, 2023
Tango Therapeutics reported fiscal year 2022 executive compensation information on April 24, 2023.
In 2022, three executives at Tango Therapeutics received on average a compensation package of $2.7M, a 53% decrease compared to previous year.
Average pay of disclosed executives at Tango Therapeutics
Barbara Weber, Chief Executive Officer, received $4.7M in total, which decreased by 59% compared to 2021. 80% of Weber's compensation, or $3.7M, was in option awards. Weber also received $364K in non-equity incentive plan, $575K in salary, as well as $2.5K in other compensation.
Alan Huang, Chief Scientific Officer, received a compensation package of $1.8M, which decreased by 18% compared to previous year. 66% of the compensation package, or $1.2M, was in option awards.
Daniella Beckman, Chief Financial Officer, earned $1.5M in 2022, a 52% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2023.